Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC

About the cover

pISSN: 1000-467X

eISSN: 1944-446X

CN: 44-1195/R

 

View OnlineFirst Articles

New articles accepted recently

View Current Issue

Volume 35 Issue 11

Browse Past Issues

From January 2002


1 Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?
     Jing Wen, Ying-Cheng Huang, Huan-Huan Xiu, Zhi-Ming Shan and Kang-Qing Xu
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-5   Downloaded: 1908
2 Cell-free circulating tumor DNA in cancer
     Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-5   Downloaded: 1769
3 Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma
     Ying Guan, Shuai Liu, Han-Yu Wang, Ying Guo, Wei-Wei Xiao, Chun-Yan Chen, Chong Zhao, Tai-Xiang Lu and Fei Han
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-4   Downloaded: 1305
4 Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis
     Ying Shi, Song-Ling Peng, Li-Fang Yang, Xue Chen, Yong-Guang Tao and Ya Cao
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-3   Downloaded: 1117
5 Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
     Shan Wang, Yan Fu and Yongzhang Luo
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 891
6 Why some tumours trigger neovascularisation and others don’t: the story thus far
     Omanma Adighibe, Russell D. Leek, Marta Fernandez-Mercado, Jiangting Hu, Cameron Snell, Kevin C. Gatter, Adrian L. Harris and Francesco Pezzella
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 974
7 Mechanisms of vascularization in murine models of primary and metastatic tumor growth
     Edina Bugyik, Ferenc Renyi-Vamos, Vanessza Szabo, Katalin Dezso, Nora Ecker, Andras Rokusz, Peter Nagy, Balazs Dome and Sandor Paku
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 3136
8 Future options of anti-angiogenic cancer therapy
     Yihai Cao
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 932
9 Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation
     Chao-Nan Qian, Min-Han Tan, Jun-Ping Yang and Yun Cao
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 1041



1 Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs
     Rishil J. Kathawala, Yi-Jun Wang, Charles R. Ashby Jr, Zhe-Sheng Chen
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2014-5   Downloaded: 9582
2 The US Chinese Anti-Cancer Association and the National Foundation for Cancer Research recognize five young Chinese investigators with the 2014 USCACA-NFCR Scholar Awards
     Wei Zhang, Lifang Hou, Li Yan, Wei Zhang, Michael Yi Wang, Shi-Yuan Cheng
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2014-11   Downloaded: 4832
3 Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
     José Antonio López-Guerrero, Ignacio Romero, Andrés Poveda
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2015-1   Downloaded: 3752
4 Mechanisms of vascularization in murine models of primary and metastatic tumor growth
     Edina Bugyik, Ferenc Renyi-Vamos, Vanessza Szabo, Katalin Dezso, Nora Ecker, Andras Rokusz, Peter Nagy, Balazs Dome and Sandor Paku
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 3136
5 Ovarian cancer standard of care: are there real alternatives?
     Chiara Della Pepa, Giuseppe Tonini, Carmela Pisano, Marilena Di Napoli, Sabrina Chiara Cecere, Rosa Tambaro, Gaetano Facchini, Sando Pignata
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2015-1   Downloaded: 3064



Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:


CJC is now published by BioMed Central

© Chinese Journal of Cancer

ICP 备案序号:粤ICP备12079158号

Sun Yat-sen University Cancer Center

651 Dongfeng Road East,Guangzhou 510060, P.R.China